Dr. Wei Yang
Claim this profileShengjing Hospital of China Medical University
Studies Cancer
Studies Plasma Cell Neoplasm
12 reported clinical trials
21 drugs studied
Clinical Trials Wei Yang is currently running
CC-99282 + Anti-Lymphoma Agents
for Non-Hodgkin's Lymphoma
This trial is testing a new drug, CC-99282, for patients with certain types of lymphoma who haven't responded to other treatments. Researchers are finding the safest dose and checking if it works better alone or with other drugs.
Recruiting1 award Phase 1 & 22 criteria
Pirtobrutinib + VR
for Chronic Lymphocytic Leukemia
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm B) in patients with CLL/SLL who have been previously treated with at least one prior line of therapy. Participation could last up to five years.
Recruiting2 awards Phase 3
More about Wei Yang
Clinical Trial Related2 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Wei Yang has experience with
- Rituximab
- Dexamethasone
- Pirtobrutinib
- CC-92480
- Carfilzomib
- CC-99282
Breakdown of trials Wei Yang has run
Cancer
Plasma Cell Neoplasm
Multiple Myeloma
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wei Yang specialize in?
Wei Yang focuses on Cancer and Plasma Cell Neoplasm. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Wei Yang currently recruiting for clinical trials?
Yes, Wei Yang is currently recruiting for 4 clinical trials in Shenyang Liaoning. If you're interested in participating, you should apply.
Are there any treatments that Wei Yang has studied deeply?
Yes, Wei Yang has studied treatments such as Rituximab, Dexamethasone, Pirtobrutinib.
What is the best way to schedule an appointment with Wei Yang?
Apply for one of the trials that Wei Yang is conducting.
What is the office address of Wei Yang?
The office of Wei Yang is located at: Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004 China. This is the address for their practice at the Shengjing Hospital of China Medical University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.